Daniel Teper
Direttore/Membro del Consiglio presso CROSSJECT
Posizioni attive di Daniel Teper
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CROSSJECT | Direttore/Membro del Consiglio | 07/06/2023 | - |
| Cytovia Holdings, Inc. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| Fondatore | - | - | |
Vector Therapeutics, Inc.
 Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY. | Amministratore Delegato | - | - |
| Presidente | - | - | |
| Fondatore | - | - | |
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Amministratore Delegato | 03/08/2018 | - |
| Presidente | 03/08/2018 | - | |
| Direttore Finanziario/CFO | 03/08/2018 | - | |
| Segretario Aziendale | 03/08/2018 | - | |
| Treasurer | 03/08/2018 | - | |
| Wintech Pharmaceuticals | Amministratore Delegato | - | - |
| Fondatore | - | - |
Storia della carriera di Daniel Teper
Precedenti posizioni note di Daniel Teper
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2010 | 01/05/2018 |
| Amministratore Delegato | 26/08/2013 | 24/04/2017 | |
| Presidente | 26/08/2013 | 15/12/2014 | |
| Fondatore | 01/01/2010 | 01/05/2018 | |
Cytovia, Inc.
 Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | 01/05/2018 |
| Amministratore Delegato | - | 01/05/2018 | |
| Fondatore | - | 01/05/2018 | |
SoftWatch, Inc.
 SoftWatch, Inc. Packaged SoftwareTechnology Services SoftWatch, Inc. provides Internet relationship management solutions and services. The company's product, SoftWatch relationship server enables companies to build and deploy healthcare portals and communities for collecting market data. It offers services to the health and pharmaceutical industries. SoftWatch was founded in 1994 and is headquartered in Pawling, NY. | Corporate Officer/Principal | - | 23/07/2010 |
| ░░░░░ ░░░░ ░░░░░ ░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░ | - | - | |
| ░░░ ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Daniel Teper
| INSEAD | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 12 |
| Francia | 7 |
| Canada | 2 |
Posizioni
| Chief Executive Officer | 8 |
| Founder | 6 |
| Director/Board Member | 5 |
Settori
| Health Technology | 9 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CROSSJECT | Health Technology |
| Aziende private | 16 |
|---|---|
Havas Life Paris SA
 Havas Life Paris SA Advertising/Marketing ServicesCommercial Services Havas Life Paris SA provides advertising and marketing services. The company is headquartered in Puteaux, France. | Commercial Services |
Cytovia, Inc.
Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Commercial Services |
SoftWatch, Inc.
SoftWatch, Inc. Packaged SoftwareTechnology Services SoftWatch, Inc. provides Internet relationship management solutions and services. The company's product, SoftWatch relationship server enables companies to build and deploy healthcare portals and communities for collecting market data. It offers services to the health and pharmaceutical industries. SoftWatch was founded in 1994 and is headquartered in Pawling, NY. | Technology Services |
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |
Phoenix BioPharm, Inc.
 Phoenix BioPharm, Inc. Pharmaceuticals: MajorHealth Technology Phoenix BioPharm, Inc. is a pharmaceutical company, which engages in marketing of therapeutics for the treatment of central nervous system, cardiovascular diseases, and specialty products. The company was founded in 2003 and is headquartered in Woodbridge, Canada. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Bionest Partners LLC
 Bionest Partners LLC Electronic Equipment/InstrumentsElectronic Technology Bionest Partners, Inc. provides consulting services to the medical industry. The firm offers expertise in all aspects of the life sciences including medical devices, diagnostics, research and development, marketing, corporate development, and personal medicine strategy. The company was founded by Robert J. Easton in 2003 and is headquartered in New York, NY. | Electronic Technology |
| Iso Healthcare Consulting | |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
| Wintech Pharmaceuticals | |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Health Technology |
| Laboratoires Delagrange | |
Vector Therapeutics, Inc.
Vector Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vector Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The firm engages in the acquisition, development, and commercialization of treatments for a variety of cancers, with a primary focus on leukemia. Its product portfolio consists initially of drugs targeting different stages and sub-types of Acute Myeloid Leukemia. The company was founded by Daniel Teper and is headquartered in New York, NY. | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
| Cytovia Holdings, Inc. |
- Borsa valori
- Insiders
- Daniel Teper
- Esperienza
